Doris Duke Foundation Award Goes to Shoemaker
August 27, 2018
On July 31, Ashley Shoemaker, M.D., MSCI, Assistant Professor of Pediatrics, was awarded a 2018 Clinical Scientist Development Award by the Doris Duke Charitable Foundation. Shoemaker will receive $495,000 over the next three years to continue her clinical study of a drug to treat pseudohypoparathyroidism (PHP), a genetic disorder characterized by early-onset obesity, short stature, cognitive impairment and increased risk of type 2 diabetes.
For the past two years, Shoemaker’s research group has collaborated with an international group of investigators in an effort to improve management and treatment of PHP. They are looking at theophylline as a possible treatment. The drug blocks an enzyme involved in the impaired hormone signaling that underlies the disease.
Shoemaker earned her medical degree from Virginia Commonwealth University, and completed her residency training at Johns Hopkins University and fellowship training in Pediatric Endocrinology at Vanderbilt. She is a graduate of Vanderbilt’s Master of Science in Clinical Investigation (MSCI) program. Shoemaker joined the Vanderbilt faculty in 2010.